Chinese Virus

Chinese Virus www.infralive.com 44 Infra LIVE April 15, 2020 headache (eight [8 pc] patients), sore throat (five [5 pc] patients), rhinorrhoea (four [4 pc] patients), chest pain (two [2 pc] patients), diarrhoea (two [2 pc] patients), and nausea and vomiting (one [1 pc] patient). According to imaging examination, 74 (75 pc) patients showed bilateral pneumonia, 14 (14 pc) patients showed multiple mo t t l i ng and g round- g l as s opacity, and one (1 pc) patient had pneumothorax. 17 (17 pc) patients developed acute respiratory distress syndrome and, among them, 11 (11 pc) patients worsened in a short period of time and died ofmultiple organ failure. Interpretation The 2019-nCoV infection was and radiological features and laboratory data. Outcomes were followed up until Jan 25, 2020. Findings Of the 99 patients with 2019- nCoV pneumonia, 49 (49 pc) had a history of exposure to the Huanan seafood market. The average age of the patients was 55.5 years (SD 13.1), including 67 men and 32 women. 2019-nCoV was detected in all patients by real-time RT- PCR. 50 (51 pc) patients had chronic diseases. Patients had clinical manifestations of fever (82 [83 pc] patients), cough (81 [82 pc] patients), shortness of breath (31 [31 pc] patients), muscle ache (11 [11 pc] patients), confusion (nine [9 pc] patients), Summary Background In December, 2019, a pneumo- nia associated with the 2019 novel c o r o n a v i r u s ( 2 0 1 9 - n C o V ) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia. Methods In this retrospective, single- centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020. Cases were confirmed by real-time RT-PCR and were analysed for epidemio- logical, demographic, clinical, Box-C: Relevant extracts of report published in www.thelancet.com Vol 395 February 15, 2020 COVID-19Critical Items List Personal protective Equip- ment PPE: r Gloves, examination r Gloves, surgical r Goggles, protective r Face shield r Mask, particulate respirator r Mask, surgical Diagnostic equipment: r Lab screening test kit (94 tests) r Lab confirmation test kit (94 tests) r RT-PCRkit (100 tests) r Lab extraction kit (250 extrac- tions) r Viral transport medium (swabs & tubes) Clinical care equipment: r Pulse oximeter - fingertip r Concentrator O2, 10L, 230V, 50 Hz + acc. r Ventilator patient, for adult, pediatric&neonatew/acc. r CPAP 10 machine, w/twin flowmeters r CPAP unit w/nasal tubing and mask for adult r Flowmeter, Thorpe tube, for oxygen0-15L/min r Suction pomp, mechanical (twin pump) r High flownasal cannula may be a sked t o s e l f - quarantine or kept quaran- tined at a healthcare facility. When To Get Tested For Covid-19? r You should get tested for C o v i d - 1 9 o n l y i f y o u experience symptoms such as fever, cough, cold, and difficulty in breathing. TestingProcess The lab will collect any of the following samples fromyou r Swab sample: The lab will take the sample from the inside of the throat using a special cotton swab. r Nasal aspirate: The lab will inject a saline solution into your nose, then remove the sample with gentle suction. r Tracheal aspirate: A thin, lighted tube called a bronchoscope goes into your lungs, where a sample will be collected. r Sputum test: Sputum is a variation of mucus from your lungs that can be coughed out or sampled fromthe nosewith a swab. r Ablood test biomaterial for approximately 12 million tablets of combination of Lopanvir and Ritonavir, old generation drugs used to treat HIV; these drugs are being used along with anti-viral flu medica- tion Oseltamivir and chloroquine as part of the treatment regimen. Each patient requires 28 tablets. What To Do If You Think You Might Be InfectedWith SARS CoV-2?. If you experience any of the signs and symptoms of COVID-19, follow these steps below to help prevent the spread of the disease. 1. Do not go to a hospital or pharmacy, instead call the State helpline number or Ministry of Health & Family Welfare's 24x7 helpline at 011- 23978046. 2. You may be asked to self- quarantine. 3. Your details will be shared with the local healthcare officials. 4. The local healthcare officials will contact you with the testing protocols of Covid-19. 5. If you qualify as a case to get tested, then you will be tested at a government approved lab. 6. Till the results come back, you